Dr. Martin Fensch
Vice President Governmental Affairs Europe/Canada – Daiichi Sankyo Europe GmbH
Dr. Martin Fensch leads Governmental Affairs & Strategic Partnerships Europe/Canada at Daiichi-Sankyo, a pharmaceutical company headquartered in Japan. The company specializes in innovative medicines for Oncology and Cardiovascular diseases. With...
Dr. Martin Fensch leads Governmental Affairs & Strategic Partnerships Europe/Canada at Daiichi-Sankyo, a pharmaceutical company headquartered in Japan. The company specializes in innovative medicines for Oncology and Cardiovascular diseases. With roots in journalism and over 18 years of experience in the pharmaceutical industry, Dr. Fensch´s focus is on building teams and external relationships while fostering a culture of diversity and trust. Prior to joining Daiichi-Sankyo in 2022, he held various national and international leadership roles at Pfizer ¬- in the areas of Policy, Communications, and Business. He served as Managing Director in the German Pfizer organization for 10 years and holds a doctorate in philosophy. In 2022, he published the book “News and Fake News on Vaccination” and periodically teaches Public Relations at the ESCP Business School. Dr. Fensch is an active member of the “Stiftung Überleben” advisory board, „Vision Zero in Oncology“ and a mentor at Schotstek, a network for young talents with a migration history.
Mehr Informationen